Article
Circulating matrix γ-carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome.
Journal of thrombosis and haemostasis : JTH - 1 Jun 2011
Cranenburg E C M, VAN Spaendonck-Zwarts K Y, Bonafe L, Mittaz Crettol L, Rödiger L A, Dikkers F G, VAN Essen A J, Superti-Furga A, Alexandrakis E, Vermeer C, Schurgers L J, Laverman G D
Abstract excerpt
BACKGROUND AND OBJECTIVES: Matrix γ-carboxyglutamate protein (MGP), a vitamin K-dependent protein, is recognized as a potent local inhibitor of vascular calcification. Studying patients with Keutel syndrome (KS), a rare autosomal recessive disorder resulting from MGP mutations, provides an opportunity to investigate the functions of MGP. The purpose of this study was (i) to investigate the phenotype and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
